These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1438107)

  • 1. Views of a general population on mass screening for colorectal cancer: the Burgundy Study.
    Arveux P; Durand G; Milan C; Bedenne L; Lévy D; Doan BD; Faivre J
    Prev Med; 1992 Sep; 21(5):574-81. PubMed ID: 1438107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation.
    Herbert C; Launoy G; Gignoux M
    Eur J Cancer Prev; 1997 Feb; 6(1):44-52. PubMed ID: 9161812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study.
    Faivre J; Arveux P; Milan C; Durand G; Lamour J; Bedenne L
    Eur J Cancer Prev; 1991 Oct; 1(1):49-55. PubMed ID: 1842684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary results of a mass screening program for colorectal cancer].
    Bedenne L; Durand G; Faivre J; Milan C; Boutron MC; Arveux P; Colombier P; Klepping C
    Gastroenterol Clin Biol; 1990; 14(2):140-5. PubMed ID: 2328881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996.
    Tazi MA; Faivre J; Dassonville F; Lamour J; Milan C; Durand G
    J Med Screen; 1997; 4(3):147-51. PubMed ID: 9368872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with participation in screening for colorectal cancer with faecal occult blood testing.
    Lindholm E; Berglund B; Haglind E; Kewenter J
    Scand J Gastroenterol; 1995 Feb; 30(2):171-6. PubMed ID: 7732341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost of a mass screening program for colorectal cancer using the occult blood test].
    Arveux P; Faivre J; Bedenne L; Durand G; Milan C; Milan C
    Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to colorectal cancer screening in an HMO population.
    Myers RE; Trock BJ; Lerman C; Wolf T; Ross E; Engstrom PF
    Prev Med; 1990 Sep; 19(5):502-14. PubMed ID: 2235919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences of patients with false positive results from colorectal cancer screening.
    Mant D; Fitzpatrick R; Hogg A; Fuller A; Farmer A; Verne J; Northover J
    Br J Gen Pract; 1990 Oct; 40(339):423-5. PubMed ID: 2271264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a risk questionnaire add anything to a colorectal screening project? Report of a 3-year screening experience.
    Niv Y
    J Clin Gastroenterol; 1992 Jul; 15(1):33-6. PubMed ID: 1500659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acceptability of the Hemoccult test in general medical practice. Results of a pilot study].
    Archambault F; Durand G; Faivre J; Voilquin JP; Archambault P; Riou F; Ageorges P; Archambault ML; Delville JM; Fesneau M
    Bull Cancer; 1989; 76(10):1071-5. PubMed ID: 2699722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mass screening for colorectal cancer].
    Faivre J; Tazi MA; Launoy G
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S7-14. PubMed ID: 8935859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mass screening of colorectal cancer by general practitioners in France: what is the real target population?].
    Desoubeaux N; Herbert C; Launoy G; Vallée JP; Bouvier V; Maurel J; Née E; Gignoux M
    Gastroenterol Clin Biol; 1997; 21(10):760-3. PubMed ID: 9587517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.